US Pharma MarketingModerna mRNA flu shot wins FDA approval but awaits CDC recommendations
Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
The approval means mFlusiva becomes the first mRNA-based vaccine to be authorised on the US market for flu prevention.
Source: Pharmaceutical Technology